Dr. Andrea Crowell is now a fellow in the Department after receiving the American Psychiatric Association Lilly Research Fellowship for 2014. Her research interests include neuromodulation, depression and the autonomic nervous system. She recently presented at two international conferences, the first entitled, "Chronic, Multi-Contact, Neural Interface for Deep Brain Stimulation" and the second entitled, "Microfabricated Polymer-Based Neural Interface for Electrical Stimulation/Record, Drug Delivery, and Chemical Sensing - Development."
Dr. David Goldsmith will be the rising Chief Resident for the Research Track. He was recently selected as a 2016 Laughlin Fellow of The American College of Psychiatrists. He was also recently awarded the Janssen Academic Research Mentorship Award and the American Psychiatric Institute on Research and Education (APIRE) Award. These awards are supporting a project examining symptomatic improvement and inflammatory markers of minocycline augmentation of clozapine in patients with persistent symptoms of schizophrenia. Dr. Goldsmith has placed two years in a row in the Joe and Hope Skobba Poser Presentation Competition at the Georgia Psychiatric Physicians Association winter meeting for his posters, “Characteristics of Persistent Antipsychotic Poly-pharmacy Recipients: Findings from a National Medicaid Dataset with a Specific Emphasis on the State of Georgia,” and “A Meta-Analysis of Cytokine Alterations in Chronically Ill Psychiatric Patients: Comparisons between Schizophrenia, Bipolar Disorder, and Major Depressive Disorder.” He will be presenting the later data at both the International Congress of Schizophrenia Research and Society of Biological Psychiatry Annual Meetings. He is currently writing up these findings for publication.
Dr. Laura Hack's research interests broadly include the use of biomarkers, including genetic variants, to aid in treatment selection for mood and anxiety disorders. She plans to complete a 2-month research intensive elective working with Dr. Elisabeth Binder, who studies genetics, epigenetics, and gene-environment interactions in mood and anxiety disorders. Dr. Binder holds a joint appointment as Associate Professor of Psychiatry and Behavioral Sciences at Emory University School of Medicine and as Managing Director at the Max-Planck Institute of Psychiatry, Munich, Germany. Dr. Hack's previous research experience involves the examination of alcohol dependence and related phenotypes using molecular genetic and twin studies. Dr. Hack has presented her work at several national conferences.
Dr. Jungjin Kim’s research interests broadly include clinical trials and psychopharmacology in both pediatric and adult patients. He plans to complete a research intensive elective working with Dr. Scahill, who studies autism at the Marcus Autism Center. Work will center on developing and testing novel treatments for autism. Dr. Kim has previously published three papers on tardive dyskinesia and use of varenicline for smoking cessation.
Dr. Neguine Rezaii is interested in examining the Whorfian hypothesis, which holds that the structure of a language affects the ways in which its respective speakers conceptualize their world. In her research track project, she is attempting to map semantic structure based on syntactic properties of verbs, and compare the result across different languages. Her past research experience includes psychopharmacological studies of anxiety in animal models in Iran, fMRI study of brain's resting state in autistic patients in Cambridge University and Event Related Potential study of emotion processing in schizophrenic patients in Harvard University. Together these resulted in 9 international poster presentations and 6 published journal articles.
Dr. Yilang Tang has been awarded scholarship from the American Association for Geriatric Psychiatry Honors Scholarship, American Academy of Addiction Psychiatry. His primary research interests include substance use disorder, clinical psychopharmacology and psychiatric genetics. Since beginning residency in 2011, he has published 30 peer-reviewed papers and several manuscripts are in press or under review. Dr. Tang was named a Janssen Resident Psychiatric Research Scholar by the American Psychiatric Association and won the Janssen Academic Research Mentorship Award. Dr. Tang was granted a fellowship to support his attendance at the American Society of Clinical Psychopharmacology Workshop on Clinical Trials. He is currently working with Dr. Kerry Ressler on the Grady Trauma Project and with Dr. Dunlop on clinical trials of mood and anxiety disorders. He has been accepted by the Emory University Addiction Psychiatry Fellowship program and plans to pursue his career as an addiction psychiatrist.